We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

BECKMAN COULTER, INC.

Beckman Coulter develops, manufactures and markets laboratory systems, reagents, centrifugation, lab automation, elec... read more Featured Products: More products

Download Mobile App




Beckman Coulter and hc1.com Enter Strategic Partnership for Innovative Healthcare Cloud System

By LabMedica International staff writers
Posted on 17 Apr 2014
Print article
The diagnostics division of Beckman Coulter (Brea, CA, USA) and hc1.com (Indianapolis, IN, USA) have announced a partnership to bring an innovative healthcare cloud-technology system to clinical laboratories. The system, hc1.com's "Healthcare Relationship Cloud," helps turn large amounts of clinical data into actionable insights that transform how laboratories manage their business and their contributions to improving healthcare. It is used in optimizing the way laboratories, radiology groups, and health systems manage their provider and patient experience across the continuum of care. A winner of the 2013 Red Herring Top 100 Global award, hc1.com is in use worldwide across 500 healthcare locations.

This hc1.com software solution helps laboratories gain real-time visibility into key metrics, including test turnaround time (TAT), test utilization by provider, and productivity per lab operator. Additionally, the solution helps to identify important issues that require immediate action, as well as alert laboratory management to issues that are most prevalent across the entire health system

The partnership creates a powerful solution for clinical laboratories by combining hc1.com’s Software-as-a-Service Healthcare Relationship Cloud with Beckman Coulter’s clinical diagnostic systems. Beckman Coulter will offer hc1.com as its exclusive healthcare relationship management solution to help laboratories in North America manage their critical business and healthcare needs more proactively and with greater intelligence.

“The partnership between Beckman Coulter and hc1.com combines two highly complementary innovators to create value that can revolutionize the healthcare industry,” said Brad Bostic, chairman and CEO, hc1.com; “The agreement will allow Beckman Coulter’s customers to transform the healthcare experience by immediately addressing important provider needs, taking action on those needs, and ultimately delivering an amazing healthcare experience to patients and providers.”

“By leveraging hc1.com’s powerful software cloud solution, laboratories will be able to utilize and interpret more data than ever before to deliver a high level of performance to patients and providers,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “Innovative solutions and offerings such as these demonstrate our strong commitment to helping laboratories address challenges while maintaining focus on improving patient outcomes.”

Related Links:

Beckman Coulter Diagnostics
hc1.com


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: Comparison of traditional histopathology imaging vs. PARS raw data (Photo courtesy of University of Waterloo)

AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis

The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.